Literature DB >> 70713

T.S.H. receptor and adenylate cyclase in undifferentiated thyroid carcinoma.

Y Abe, Y Ichikawa, M Homma, K Ito, T Mimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70713     DOI: 10.1016/s0140-6736(77)91629-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Morphological demonstration and quantification of TSH binding sites in neoplastic and non-neoplastic thyroid tissues. An autoradiographic study using 125I-labelled thyrotropin.

Authors:  S Schröder; H W Müller-Gärtner; R Schroiff; P Schmiegelow; A Niendorf; W Böcker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture.

Authors:  M Laburthe; M Rousset; C Boissard; G Chevalier; A Zweibaum; G Rosselin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Thyrotropin receptor-adenylate cyclase system in plasma membranes from normal and diseased human thyroid glands.

Authors:  P Carayon; M Guibout; S Lissitzky
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

4.  The adenylate cyclase-cyclic AMP-phosphodiesterase system in pathological human thyroid.

Authors:  V Macchia; E Mandato; C Carella; G Pisano; G Biscaglia
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

5.  Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.

Authors:  T Saito; T Endo; A Kawaguchi; M Ikeda; R Katoh; A Kawaoi; A Muramatsu; T Onaya
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

6.  Microfluorimetric and X-ray microanalytic studies on the DNA content and Na+:K+ ratios of the cell nuclei in various types of thyroid tumors.

Authors:  G L Lukács; I Nagy; G Lustyik; G Balázs
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.